Pediatric Tuberculosis Research and Development: Progress, Priorities and Funding Opportunities
Lindsay McKenna,
Ani Herna Sari,
Sushant Mane,
Anna Scardigli,
Grania Brigden,
Vanessa Rouzier,
Mercedes C. Becerra,
Anneke C. Hesseling,
Farhana Amanullah
Affiliations
Lindsay McKenna
Treatment Action Group, TB Project, New York, NY 10004, USA
Ani Herna Sari
Global TB Community Advisory Board (TB CAB), Social Science Student at Airlangga University, Surabaya 60286, Indonesia
Sushant Mane
State Pediatric Centre of Excellence for Tuberculosis, Department of Pediatrics, Grant Government Medical College, Sir J.J. Group of Hospitals, Mumbai 400008, India
Anna Scardigli
The Global Fund to Fight AIDS, Tuberculosis and Malaria, 1218 Geneva, Switzerland
Grania Brigden
The Global Fund to Fight AIDS, Tuberculosis and Malaria, 1218 Geneva, Switzerland
Vanessa Rouzier
Department of Pediatrics, GHESKIO Centers, Port-au-Prince HT-6110, Haiti
Mercedes C. Becerra
Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA 02115, USA
Anneke C. Hesseling
Desmond Tutu TB Centre, Stellenbosch University, Cape Town Stellenbosch 7600, South Africa
Farhana Amanullah
Department of Pediatrics, The Indus Hospital and Health Network, The Aga Khan University Hospital, Karachi 75500, Pakistan
In this article, we highlight technological pediatric TB research advances across the TB care cascade; discuss recently completed or ongoing work in adults and corresponding significant research gaps for children; and offer recommendations and opportunities to increase investments and accelerate pediatric TB R&D.
